Injectable sustained release PLA microparticles prepared by solvent evaporation-media milling technology

References

• Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10:e1001547.
   PubMed Web of Science ®Google Scholar
• Kraft K. Depression and depressive symptoms. Mmw Fortschr Med. 2010;152:20–21.
   Google Scholar
• Höybye C, Christiansen JS. Growth hormone replacement in adults – current standards and new perspectives. Best Pract Res Clin Endocrinol Metabol. 2015;29:115–123.
   PubMed Web of Science ®Google Scholar
• Covell NH, Mcevoy JP, Schooler NR, et al. Effectiveness of switching from long-acting injectable fluphenazine or haloperidol decanoate to long-acting injectable risperidone microspheres: an open-label, randomized controlled trial. J Clin Psychiatry 2012;73:669–675.
   PubMed Web of Science ®Google Scholar
• Chen FZ, Zheng LU. Development of agomelatine in the treatment of insomnia. World Clin Drugs 2011;32:214–218.
   Google Scholar
• Ishii S, Kaneko J, Nagasaki Y. Development of a long-acting, protein-loaded, redox-active, injectable gel formed by a polyion complex for local protein therapeutics. Biomaterials. 2016;84:210.
   PubMed Web of Science ®Google Scholar
• Bartova L, Dold M, Praschak-Rieder N, et al. Intramuscular maintenance treatment with ultra-high-dose long-acting injectable aripiprazole in an elderly patient suffering from chronic refractory schizophrenia: a case report. Eur Psychiatry 2016;33:S573.
   Google Scholar
• Jaffe GJ, Lin P, Keenan RT, et al. Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis. Ophthalmology 2016;123:1940–1948.
   PubMed Web of Science ®Google Scholar
• Mertz N, Larsen SW, Kristensen J, et al. Long-acting diclofenac ester prodrugs for joint injection: kinetics, mechanism of degradation, and in vitro release from prodrug suspension. J Pharm Sci. 2016;105:3079–3087.
   PubMed Web of Science ®Google Scholar
• Rhee YS, Sohn MJ, Woo BH, et al. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. Aaps Pharmscitech. 2011;12:1293–1301.
   PubMed Web of Science ®Google Scholar
• Li J, Stayshich RM, Meyer TY. Exploiting sequence to control the hydrolysis behavior of biodegradable PLGA copolymers. J Am Chem Soc. 2011;133:6910–6913.
   PubMed Web of Science ®Google Scholar
• Tan HY, Widjaja E, Boey F, et al. Spectroscopy techniques for analyzing the hydrolysis of PLGA and PLLA. J Biomed Mater Res Part B Appl Biomater. 2009;91:433–440.
   PubMedGoogle Scholar
• Kumar R, Palmieri MJ. Points to consider when establishing drug product specifications for parenteral microspheres. Aaps J. 2010;12:27–32.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release. 2003;90:261–280.
   PubMed Web of Science ®Google Scholar
• Harrison TS, Goa KL. Long-acting risperidone: a review of its use in schizophrenia. Cns Drugs. 2004;18:113–132.
   PubMed Web of Science ®Google Scholar
• Ramazani F, Chen W, van Nostrum CF, et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges. Int J Pharm. 2016;499:358.
   PubMed Web of Science ®Google Scholar
• Marquette S, Peerboom C, Yates A, et al. Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres. Int J Pharm. 2014;470:41.
   PubMed Web of Science ®Google Scholar
• Shirley M, Perry CM. Aripiprazole (ABILIFY MAINTENA): a review of its use as maintenance treatment for adult patients with schizophrenia. Drugs. 2014;74:1097–1110.
   Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3:785–796.
   PubMed Web of Science ®Google Scholar
• Liu J, Xiao Y, Allen C. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. J Pharm Sci. 2004;93:132–143.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang S, Wang S, et al. Initial drug dissolution from amorphous solid dispersions controlled by polymer dissolution and drug-polymer interaction. Pharm Res. 2016;33:2445– 2414.
   PubMed Web of Science ®Google Scholar
• Paseta L, Potier G, Abbott S, et al. Using Hansen solubility parameters to study the encapsulation of caffeine in MOFs. Org Biomol Chem. 2015;13:1724–1731.
   PubMed Web of Science ®Google Scholar
• Latere Dwan'Isa JP, Rouxhet L, Préat V, et al. Prediction of drug solubility in amphiphilic di-block copolymer micelles: the role of polymer-drug compatibility. Pharmazie. 2007;62:499–504.
   PubMed Web of Science ®Google Scholar
• Bitterlich A, Laabs C, Krautstrunk I, et al. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling. Eur J Pharm Biopharm. 2015;92:171.
   PubMed Web of Science ®Google Scholar
• Howard MD, Lu X, Jay M, et al. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Dev Ind Pharm. 2012;38:1270.
   PubMed Web of Science ®Google Scholar
• Hu L, Kong D, Hu Q, et al. Evaluation of high-performance curcumin nanocrystals for pulmonary drug delivery both in vitro and in vivo. Nanoscale Res Lett. 2015;10:381.
   PubMed Web of Science ®Google Scholar
• Meghana M, Thota S, Venisetty RK. Development and validation of stability-indicating RP-HPLC method for the estimation of agomelatine in API. Res J Pharmaceut Biol Chem Sci. 2014;5:621–628.
   Google Scholar
• Santander-Ortega MJ, Jódar-Reyes AB, Csaba N, et al. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J Colloid Interface Sci. 2006;302:522–529.
   PubMed Web of Science ®Google Scholar
• Turino LN, Mariano RN, Boimvaser S, et al. In situ-formed microparticles of PLGA from O/W emulsions stabilized with PVA: encapsulation and controlled release of progesterone. J Pharm Innov. 2014;9:132–140.
   Web of Science ®Google Scholar
• Souvie JC, Gonzalez-Blanco I, Thominot G, et al. Process for the synthesis and crystalline form agomelatine. US, US7544839. 2009.
   Google Scholar
• Barton AFM. CRC handbook of solubility parameters and other cohesion parameters. CRC Pr; 1983.
   Google Scholar